Session 2: Small Molecule Metabolites in Drug Discovery and Development

Only available as part of a package

Chairs: Aaron Teitelbaum, Bingming Chen, Carley Heck, and Matthew Albertolle

The Human ADME Study: Comparison of Various Strategies and Technical Approaches

image


Chandra Prakash, Agios




Accelerator Mass Spectrometry for the Support of Microtracer Studies @ Boehringer-Ingelheim, Technical Aspects of AMS' Deep Dive on How AMS Actually Works

image


 Stefan Blech, Boehringer Ingelheim



image



Ralf Laux, Boehringer Ingelheim



How to Deal with Metabolites from Human ADME: Part 1. MIST 

image


Yuexia Liang, Merck



Assessing Metabolite Contribution to Target Activity and DDI 

image


Sheila Peters, Boehringer Ingelheim




Roundtable Discussion with Speakers

Key:

Complete
Failed
Available
Locked
Session 2: Small Molecule Metabolites in Drug Discovery and Development
Recorded 03/02/2023  |  60 minutes
Recorded 03/02/2023  |  60 minutes Time Stamps: 0:00 - Welcome and Introduction 5:08 - Chandra Prakash's Presentation: The Human ADME Study: Comparison of Various Strategies and Technical Approaches 44:35 - Stefan Blech's and Ralf Laux's Presentation: Accelerator Mass Spectrometry for the Support of Microtracer Studies @ Boehringer-Ingelheim, Technical Aspects of AMS' Deep Dive on How AMS Actually Works 1:30:15 - Yuexia Liang's Presentation: How to Deal with Metabolites from Human ADME: Part 1. MIST 2:14:17 - Sheila Peter's Presentation: Assessing Metabolite Contribution to Target Activity and DDI 2:47: 03 - Panel Discussion
You must register to access.